Related references
Note: Only part of the references are listed.Tumor-induced CD11b(+)Gr-1(+) myeloid cells suppress T cell Sensitization in tumor-draining lymph nodes
Satoshi Watanabe et al.
JOURNAL OF IMMUNOLOGY (2008)
Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells:: Implications and impact on tumor-mediated immune suppression
Laura Strauss et al.
JOURNAL OF IMMUNOLOGY (2008)
Expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells:: Applicability to tumor-infiltrating T regulatory cells
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
NKT cells in tumor immunity: Opposing subsets define a new immunoregulatory axis
Jay A. Berzofsky et al.
JOURNAL OF IMMUNOLOGY (2008)
Targeting the effector site with IFN-αβ-inducing TLR ligands reactivates tumor-resident CD8 T cell responses to eradicate established solid tumors
Andrew J. Currie et al.
JOURNAL OF IMMUNOLOGY (2008)
CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells
Irina Fernandez et al.
JOURNAL OF IMMUNOLOGY (2007)
Infiltration of a mesothelioma by IFN-γ-producing cells and tumor rejection after depletion of regulatory T cells
Geordie Rudge et al.
JOURNAL OF IMMUNOLOGY (2007)
Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance
Gang Zhou et al.
JOURNAL OF IMMUNOLOGY (2007)
Chemoimmunotherapy of tumors:: Cyclophosphamide synergizes with exosome based vaccines
Julien Taieb et al.
JOURNAL OF IMMUNOLOGY (2006)
Cyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanism
B Peláez et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
